Literature DB >> 15339997

Retinal microvascular abnormalities and renal dysfunction: the atherosclerosis risk in communities study.

Tien Yin Wong1, Josef Coresh, Ronald Klein, Paul Muntner, David J Couper, A Richey Sharrett, Barbara E K Klein, Gerardo Heiss, Larry D Hubbard, Bruce B Duncan.   

Abstract

Microvascular disease has been linked with renal dysfunction in patients with diabetes. The aim of this study was to examine the association of retinal microvascular abnormalities to renal dysfunction among participants of the Atherosclerosis Risk in Communities Study, a population-based investigation in four U.S. communities. At the third examination (1993 to 1995), retinal photography was performed and the presence of retinal microvascular abnormalities was documented using a standard grading protocol. Renal dysfunction was defined as an increase in serum creatinine of at least 0.4 mg/dl or a death or hospitalization as a result of chronic kidney disease between the second (1990 to 1992) and fourth (1996 to 1998) examinations. Among 10,056 people who were included in the study, 270 (2.7%) developed renal dysfunction. After controlling for age, gender, race, diabetes, BP, and other risk factors, individuals with retinopathy (odds ratio [OR], 2.0; 95% confidence interval [CI], 1.4 to 2.8), microaneurysms (OR, 2.0; 95% CI, 1.3 to 3.1), retinal hemorrhages (OR, 2.6; 95% CI, 1.6 to 4.0), soft exudates (OR, 2.7; 95% CI, 1.6 to 4.8), and arteriovenous nicking (OR, 1.4; 95% CI, 1.0 to 1.9) were more likely to develop renal dysfunction than individuals without these abnormalities. Retinal microvascular abnormalities are associated with renal dysfunction, suggesting that common systemic microvascular processes may underlie the development of microvascular damage in the eye and kidneys.

Entities:  

Mesh:

Year:  2004        PMID: 15339997     DOI: 10.1097/01.ASN.0000136133.28194.E4

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  77 in total

1.  Serum Phosphate and Retinal Microvascular Changes: The Multi-Ethnic Study of Atherosclerosis and the Beaver Dam Eye Study.

Authors:  Rupal Mehta; Alexander Hodakowski; Xuan Cai; Kris E Lee; Bryan R Kestenbaum; Ian H de Boer; Amani Fawzi; Tien Yin Wong; Joachim Ix; Barbara Klein; Ronald Klein; Tamara Isakova
Journal:  Ophthalmic Epidemiol       Date:  2017-04-12       Impact factor: 1.648

Review 2.  Cerebrovascular complications of diabetes: focus on cognitive dysfunction.

Authors:  Trevor Hardigan; Rebecca Ward; Adviye Ergul
Journal:  Clin Sci (Lond)       Date:  2016-10-01       Impact factor: 6.124

3.  Retinal vessel caliber among people with acquired immunodeficiency syndrome: relationships with disease-associated factors and mortality.

Authors:  Sapna Gangaputra; Partho S Kalyani; Amani A Fawzi; Mark L Van Natta; Larry D Hubbard; Ronald P Danis; Jennifer E Thorne; Gary N Holland
Journal:  Am J Ophthalmol       Date:  2011-10-22       Impact factor: 5.258

4.  Prevalence of ocular fundus pathology in patients with chronic kidney disease.

Authors:  Juan E Grunwald; Judith Alexander; Maureen Maguire; Revell Whittock; Candace Parker; Kathleen McWilliams; Joan C Lo; Raymond Townsend; Crystal A Gadegbeku; James P Lash; Jeffrey C Fink; Mahaboob Rahman; Harold Feldman; John Kusek; Akinlolu Ojo
Journal:  Clin J Am Soc Nephrol       Date:  2010-03-18       Impact factor: 8.237

Review 5.  Hypertensive retinopathy revisited: some answers, more questions.

Authors:  A Grosso; F Veglio; M Porta; F M Grignolo; T Y Wong
Journal:  Br J Ophthalmol       Date:  2005-12       Impact factor: 4.638

6.  Retinopathy and progression of CKD: The CRIC study.

Authors:  Juan E Grunwald; Maxwell Pistilli; Gui-Shuang Ying; Ebenezer Daniel; Maureen G Maguire; Dawei Xie; Revell Whittock-Martin; Candace Parker Ostroff; Joan C Lo; Raymond R Townsend; Crystal A Gadegbeku; James P Lash; Jeffrey C Fink; Mahboob Rahman; Harold I Feldman; John W Kusek
Journal:  Clin J Am Soc Nephrol       Date:  2014-05-08       Impact factor: 8.237

7.  Phosphate, fibroblast growth factor 23 and retinopathy in chronic kidney disease: the Chronic Renal Insufficiency Cohort Study.

Authors:  Rupal Mehta; Gui Shuang Ying; Samuel Houston; Tamara Isakova; Lisa Nessel; Akinlolu Ojo; Alan Go; Jim Lash; John Kusek; Juan Grunwald; Myles Wolf
Journal:  Nephrol Dial Transplant       Date:  2015-04-24       Impact factor: 5.992

8.  Chronic kidney disease and the severity of coronary artery disease and retinal microvasculature changes: a cross-sectional study.

Authors:  Kevin Phan; Cheryl Au; Paul Mitchell; Gerald Liew; Adam J H Plant; Sarah B Wang; Joseph Chiha; Aravinda Thiagalingam; George Burlutsky; Bamini Gopinath
Journal:  J Thorac Dis       Date:  2016-08       Impact factor: 2.895

9.  Retinopathy and CKD as predictors of all-cause and cardiovascular mortality: National Health and Nutrition Examination Survey (NHANES) 1988-1994.

Authors:  Ana C Ricardo; Juan E Grunwald; Sharmila Parvathaneni; Sean Goodin; Alice Ching; James P Lash
Journal:  Am J Kidney Dis       Date:  2014-03-19       Impact factor: 8.860

10.  Diabetic retinopathy and renal function in Chinese type 2 diabetic patients.

Authors:  Huiyan Zhang; Jianyong Wang; Gui-shuang Ying; Liping Shen; Zhe Zhang
Journal:  Int Urol Nephrol       Date:  2014-02-27       Impact factor: 2.370

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.